Pregnancy Complicated by Tuberculous Lymphadenitis and PPROM Following Contraceptive Failure: A Case Report
Abstract
Introduction: Tuberculous lymphadenitis during pregnancy is associated with increased risks of adverse maternal and perinatal outcomes. Rifampin-based anti-tuberculosis therapy may reduce the effectiveness of hormonal contraception and lead to unintended pregnancy.
Case presentation: A 25 – 26-week pregnant woman (G2P1A0) was diagnosed with preterm premature rupture of membranes (PPROM) and threatened preterm labor. The pregnancy occurred despite levonorgestrel implant use during rifampicin therapy for tuberculous lymphadenitis. Conservative management with antibiotics, tocolytics, corticosteroids, and continuation of anti-tuberculosis therapy was initiated. However, the patient delivered an extremely preterm infant (820 g) through vaginal birth after cesarean (VBAC). The neonate died on day 14 due to complications of prematurity, while the mother recovered well after completing anti-tuberculosis treatment.
Conclusion: This case highlights contraceptive implant failure during rifampin therapy, resulting in unintended pregnancy and severe obstetric complications, including preterm birth. Tuberculosis screening, appropriate contraceptive counseling, and multidisciplinary management are essential to optimize maternal and neonatal outcomes.
Kehamilan yang Komplikasi oleh Limfadenitis Tuberkulosis dan PPROM setelah Kegagalan Kontrasepsi: Laporan Kasus
Abstrak
Pendahuluan: Limfadenitis tuberkulosis pada kehamilan berhubungan dengan peningkatan risiko komplikasi maternal dan perinatal. Terapi berbasis rifampisin dapat menurunkan efektivitas kontrasepsi hormonal dan menyebabkan kehamilan yang tidak direncanakan.
Laporan kasus: Seorang wanita hamil 25 – 26 minggu (G2P1A0) didiagnosis dengan ketuban pecah dini preterm dan partus prematurus imminens. Kehamilan terjadi meskipun menggunakan implan levonorgestrel selama terapi rifampisin untuk limfadenitis tuberkulosis. Penatalaksanaan konservatif berupa antibiotik, tokolitik, kortikosteroid, dan terapi anti-tuberkulosis diberikan. Namun, pasien melahirkan bayi prematur ekstrem (820 g) secara VBAC. Bayi meninggal pada hari ke-14 akibat komplikasi prematuritas, sedangkan kondisi ibu membaik setelah menyelesaikan terapi.
Kesimpulan: Kasus ini menunjukkan kegagalan implan kontrasepsi selama terapi rifampisin yang menyebabkan kehamilan tidak direncanakan dan persalinan prematur. Skrining tuberkulosis, konseling kontrasepsi, dan perawatan multidisiplin sangat penting.
Keywords
Full Text:
PDFReferences
Miele K, Bamrah Morris S, Tepper NK. Tuberculosis in Pregnancy. Obstetrics & Gynecology. 2020 Jun;135(6):1444–53. doi:10.1097/AOG.0000000000003890
Sobhy S, Babiker Z, Zamora J, Khan K, Kunst H. Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta‐analysis. BJOG. 2017 Apr 11;124(5):727–33. doi:10.1111/1471-0528.14408
Lazorwitz A, Sheeder J, Teal S. The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study. Contraception. 2023 Jul;123:110035. doi:10.1016/j.contraception.2023.110035
Tufa TH, Fessehaye A, Abubeker FA. Etonogestrel contraceptive implant failure in a woman taking rifampin: a case report. Contracept Reprod Med. 2022 Dec 5;7(1):5. doi:10.1186/s40834-022-00172-1
Neamțu SI, Sava M, Bereanu AS, Bădilă RM, Codru IR, Vintilă BI, et al. Evaluation of Maternal Inflammatory Biomarkers in Preterm Prelabor Rupture of Membranes: A Systematic Review and Meta-Analysis. Medicina (B Aires). 2025 Dec 22;62(1):20. doi:10.3390/medicina62010020
Cervantes EM, Girard S. Placental Inflammation in Preterm Premature Rupture of Membranes and Risk of Neurodevelopmental Disorders. Cells. 2025 Jun 24;14(13):965. doi:10.3390/cells14130965
Kacerovsky M, Vrbacky F, Matulova J, Bolehovska R, Kukla R, Pavlikova L, et al. Late preterm prelabor rupture of membrane (>33 weeks): the risk of intraamniotic inflammation and fetal inflammation is influenced by the cervical microbial ecosystem and cervical inflammation. Am J Obstet Gynecol. 2025 Nov;233(5):479.e1-479.e18. doi:10.1016/j.ajog.2025.06.017
Xiang Q, Yan X, Shi X, Huang Y, Li L, Zhong J, et al. Prolonged premature rupture of membranes with increased risk of infection is associated with gut accumulation of Pseudomonas from the environment. Comput Struct Biotechnol J. 2024 Dec;23:2851–60. doi:10.1016/j.csbj.2024.07.007
Jiang Y, Zhang Y, Li Y, Zhao K, Zhao Y, Che Y. Determinants for premature rupture of membranes: a prospective cohort study. BMC Pregnancy Childbirth. 2025 May 30;25(1):633. doi:10.1186/s12884-025-07748-0
Rahmawati A, Judistiani RTD, Setiawati DA, Fajri R, Putri S, Ruslami R. Pulmonary tuberculosis cases in pregnancy: perinatal outcomes and health promotion challenges in Indonesia. The Journal of Infection in Developing Countries. 2022 Aug 30;16(08):1372–5. doi:10.3855/jidc.15476
Ernawati E, Prasetya RE, Aditiawarman A, Sulistyono A, Akbar MIA. Risk Factors Associated With the Case Fatality Rate of Pulmonary Tuberculosis in Pregnancy: A Five-Year Retrospective Study From a Developing Country. Cureus. 2023 Nov 7. doi:10.7759/cureus.48446
Indra Adi Susianto, Jessica Christanti, Nur Dian Rakhmawati, Ririn Nurmandhani. Prevalence of Tuberculosis in Pregnant Women in Semarang. The International Conference on Public Health Proceeding. 2022;7(1).
Sulistiyani S, Darundiati YH, Raharjo M, Irawati S, Kurniawan AP, Sari NP, et al. Spatial and Epidemiological Patterns of Tuberculosis in Semarang City (2022–2024). Univers J Public Health. 2025 May;13(3):697–706. doi:10.13189/ujph.2025.130318
Simmons K, Haddad L, Nanda K, Curtis K. Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review. BJOG. 2018 Jun 15;125(7):804–11. doi:10.1111/1471-0528.15027
Hui SYA, Lao TT. Tuberculosis in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85:34–44. doi:10.1016/j.bpobgyn.2022.07.006
Priya AL, Ravi PN. Extra Pulmonary Tuberculosis in Pregnancy: A Case Report. Journal of Clinical And Diagnostic Research. 2023. doi:10.7860/JCDR/2023/56792.18004
Zurina Z, Nunis MA, Abdulla AFA, Osman M, Zakaria N. Adverse neonatal outcome associated with maternal tuberculosis in a public tertiary centre: a retrospective cohort study. Med J Malaysia. 2024 May;79(3):337–41. PubMed PMID: 38817068.
Jacobsson B, Simpson JL. FIGO good practice recommendations for reducing preterm birth and improving child outcomes. International Journal of Gynecology & Obstetrics. 2021 Oct 14;155(1):1–4. doi:10.1002/ijgo.13863
exceptional surveillance of preterm labour and birth (NICE guideline NG25). 2022. PubMed PMID: 37184184.
Su Y, Kong X, Chen Z, Wang X, Lu S. Adverse pregnancy outcomes and complications of tuberculosis in pregnant women. Front Cell Infect Microbiol. 2025 Oct 2;15. doi:10.3389/fcimb.2025.1550430
K.J. S, A. B, G.K. H, S.M. G. Tuberculosis in pregnant women and neonates: A meta-review of current evidence. Paediatr Respir Rev. 2020 Nov;36:27–32. doi:10.1016/j.prrv.2020.02.001
Crocker-Buque T, Lachenal N, Narasimooloo C, Abdrasuliev T, Parpieva N, Tigay Z, et al. Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL. Clinical Infectious Diseases. 2024 Aug 16;79(2):569–70. doi:10.1093/cid/ciad767
Alene KA, Murray MB, van de Water BJ, Becerra MC, Atalell KA, Nicol MP, et al. Treatment Outcomes Among Pregnant Patients With Multidrug-Resistant Tuberculosis. JAMA Netw Open. 2022 Jun 10;5(6):e2216527. doi:10.1001/jamanetworkopen.2022.16527
Battarbee AN, Osmundson SS, McCarthy AM, Louis JM. Society for Maternal-Fetal Medicine Consult Series #71: Management of previable and periviable preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2024 Oct;231(4):B2–15. doi:10.1016/j.ajog.2024.07.016
Klebanoff MA, Schuit E, Lamont RF, Larsson P, Odendaal HJ, Ugwumadu A, et al. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: Systematic review and individual participant data meta‐analysis. Paediatr Perinat Epidemiol. 2023 Mar 18;37(3):239–51. doi:10.1111/ppe.12947
DOI: http://dx.doi.org/10.24198/obgynia.v9i3.1107
Refbacks
- There are currently no refbacks.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
_CROSREF22.jpg)










